PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $630,000 | +8.2% | 200,000 | 0.0% | 0.29% | -4.0% |
| Q2 2020 | $582,000 | +3.2% | 200,000 | 0.0% | 0.30% | -25.6% |
| Q1 2020 | $564,000 | -13.2% | 200,000 | 0.0% | 0.40% | +52.1% |
| Q4 2019 | $650,000 | -99.8% | 200,000 | 0.0% | 0.26% | +40.2% |
| Q3 2019 | $432,000,000 | +68689.8% | 200,000 | 0.0% | 0.19% | -21.2% |
| Q2 2019 | $628,000 | -100.0% | 200,000 | 0.0% | 0.24% | -92.4% |
| Q1 2019 | $7,326,000,000 | +1163.1% | 200,000 | 0.0% | 3.14% | +971.0% |
| Q4 2018 | $580,000,000 | – | 200,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |